JPM vs NAZ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NAZ exhibits a stable financial profile with a Piotroski F-Score of 5/9 and a strong liquidity position (Current Ratio 4.04). While the fund shows positive price momentum over the last year (+12.8%), it currently trades at a premium to its book value (P/B 1.13), which limits immediate value upside. The dividend profile is a primary strength with a 6.25% yield and a sustainable payout ratio of 54.59%. However, the contradiction between the provided Technical Trend score (10/100) and actual price performance suggests volatility or a potential trend reversal.
Compare Another Pair
Related Comparisons
JPM vs NAZ: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Nuveen Arizona Quality Municipal Income Fund (NAZ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.